GPX4 and cancer: Lack of SLC7A11 and knockdown of GPX4 have been demonstrated to increase ROS-mediated lipid peroxidation and induce subsequent ferroptosis in even resistant cancer cells, indicating that deficiency in antiferroptotic function enhances cancer cell death (Yang et al., 2014; Roh et al., 2016).